12 min read
Blog | Veristat, The Science-First CRO
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
4 min read
Monthly FDA Guidance and Regulatory News Review - June 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
3 min read
FSP/Resourcing: Meeting the Moment with Expert Resources
Clinical trial leaders in small and medium-sized biotech companies regularly find themselves at the intersection of growing requirements, shrinking timelines, and talent shortages. With organizational restructuring and staffing reductions continuing,...
2 min read
Monthly FDA Guidance and Regulatory News Review - May 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
1 min read
Achieve Regulatory Excellence and Accelerate Your Clinical Trials with Veristat
Learn how Veristat’s multidisciplinary team helped sponsors navigate the complexities of global regulatory submissions, achieving early and successful outcomes.
4 min read
Webinar Q&A: How to Advance New Cancer Therapies in Alignment with FDA Project FrontRunner
Last month, in partnership with Clinical Leader, Veristat consulting, regulatory, and clinical experts gave a live webinar outlining how to better advance new cancer therapies in alignment with FDA’s Project FrontRunner. The webinar covered the following:
5 min read
Monthly FDA Guidance and Regulatory News Review - April 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
1 min read
Harness the FDA's Project FrontRunner to Advance Your New Oncology Therapies
Are you interested in learning about the latest FDA initiative to accelerate the development of new cancer treatments? Veristat's informative webinar "Advancing Development of New Oncology Therapies, aligning with FDA's Project FrontRunner" is an...
4 min read
Monthly FDA Guidance and Regulatory News Review - March 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
1 min read
How Veristat Helped a Global Pharma Company Navigate Complex Medical Writing Challenges
Learn how Veristat's expert medical writing team supported a global specialty pharmaceutical company with 130+ projects for rare disease treatments. Our longstanding thirteen-year relationship, built on trust and quality, continues to thrive as we help...